Clinical trial
HRQoL and Development of Health Utilities in Patients With Keratinocyte Carcinomas
NCT04814953 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HRQoL and Development of Health Utilities in Patients With Keratinocyte Carcinomas
- Lead sponsor
- University Hospital, Ghent
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 1, 2020
- Completion date
- December 31, 2025
- Enrollment
- 2,400 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
actinic keratoses, basal cell carcinoma, squamous cell carcinoma